These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16566292)

  • 1. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.
    Van Bambeke F; Barcia-Macay M; Lemaire S; Tulkens PM
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):218-30. PubMed ID: 16566292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics/Pharmacodynamics for critical care clinicians.
    Quintiliani R; Quintiliani R
    Crit Care Clin; 2008 Apr; 24(2):335-48, xi. PubMed ID: 18361949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?
    Theuretzbacher U
    Curr Opin Pharmacol; 2007 Oct; 7(5):498-504. PubMed ID: 17616438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic therapy: from pharmacology to decision making].
    Potel G; Caillon J; Bugnon D
    Rev Prat; 2003 Sep; 53(14):1554-60. PubMed ID: 15185662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing drug exposure to minimize selection of antibiotic resistance.
    Olofsson SK; Cars O
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S129-36. PubMed ID: 17683017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?
    Pea F; Viale P
    Clin Infect Dis; 2006 Jun; 42(12):1764-71. PubMed ID: 16705585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections.
    Baudoux P; Bles N; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2007 Feb; 59(2):246-53. PubMed ID: 17220162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimization of antibiotics in combination].
    Zhang LH; Wang LF; Meng ZY; Yu QP; Gao BQ; Ba T; Wang XD; Ma WH; Li YY; Zhang J
    Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):93-6. PubMed ID: 18785405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations.
    Bergman SJ; Speil C; Short M; Koirala J
    Infect Dis Clin North Am; 2007 Sep; 21(3):821-46, x. PubMed ID: 17826625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus.
    Nguyen HA; Grellet J; Dubois V; Saux MC; Quentin C
    J Antimicrob Chemother; 2007 Apr; 59(4):755-8. PubMed ID: 17353222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake, transport, delivery, and intracellular activity of antimicrobial agents.
    Mandell GL
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):130S-133S. PubMed ID: 16305282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy.
    Gumbo T
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics: relation to antimicrobial resistance.
    Rybak MJ
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients.
    Cheatham SC; Kays MB; Smith DW; Wack MF; Sowinski KM
    Pharmacotherapy; 2008 Jun; 28(6):691-8. PubMed ID: 18503396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular pharmacodynamics of antibiotics.
    Carryn S; Chanteux H; Seral C; Mingeot-Leclercq MP; Van Bambeke F; Tulkens PM
    Infect Dis Clin North Am; 2003 Sep; 17(3):615-34. PubMed ID: 14711080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of cefovecin in dogs.
    Stegemann MR; Sherington J; Blanchflower S
    J Vet Pharmacol Ther; 2006 Dec; 29(6):501-11. PubMed ID: 17083454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.